Open Access

Validation of commonly used reference genes for sleep-related gene expression studies

  • Kil S Lee1Email author,
  • Tathiana A Alvarenga2,
  • Camila Guindalini2,
  • Monica L Andersen2,
  • Rosa MRPS Castro2 and
  • Sergio Tufik2
BMC Molecular Biology200910:45

https://doi.org/10.1186/1471-2199-10-45

Received: 20 January 2009

Accepted: 15 May 2009

Published: 15 May 2009

Abstract

Background

Sleep is a restorative process and is essential for maintenance of mental and physical health. In an attempt to understand the complexity of sleep, multidisciplinary strategies, including genetic approaches, have been applied to sleep research. Although quantitative real time PCR has been used in previous sleep-related gene expression studies, proper validation of reference genes is currently lacking. Thus, we examined the effect of total or paradoxical sleep deprivation (TSD or PSD) on the expression stability of the following frequently used reference genes in brain and blood: beta-actin (b-actin), beta-2-microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and hypoxanthine guanine phosphoribosyl transferase (HPRT).

Results

Neither TSD nor PSD affected the expression stability of all tested genes in both tissues indicating that b-actin, B2M, GAPDH and HPRT are appropriate reference genes for the sleep-related gene expression studies. In order to further verify these results, the relative expression of brain derived neurotrophic factor (BDNF) and glycerol-3-phosphate dehydrogenase1 (GPD1) was evaluated in brain and blood, respectively. The normalization with each of four reference genes produced similar pattern of expression in control and sleep deprived rats, but subtle differences in the magnitude of expression fold change were observed which might affect the statistical significance.

Conclusion

This study demonstrated that sleep deprivation does not alter the expression stability of commonly used reference genes in brain and blood. Nonetheless, the use of multiple reference genes in quantitative RT-PCR is required for the accurate results.

Background

Sleep is a complex phenotype that involves several neurochemical and physiological processes. It is known to perform restorative functions and to facilitate memory consolidation [1, 2]. Although sleep is essential for overall well-being and optimal physical and psychological functioning, chronic sleep restriction is frequently experienced due to contemporary social and domestic responsibilities, medical conditions and sleep disorders [3]. Sleep restriction alters sleep architecture primarily by decreasing the duration of the REM (rapid eye movement) sleep stage, also known as paradoxical sleep (PS) [3]. Therefore, approaches that reduce or abolish PS have been used to simulate chronic sleep restriction.

Persistent sleep debt impairs neurobehavioral functions [3, 4] and increases the risk for chronic diseases such as cardiovascular disorders [5], erectile dysfunction [6] and diabetes [7]. Thus, careful characterization of the effects of sleep deprivation not only improves our knowledge about the complex sleep process but also contributes to elucidation of the mechanism underlying these chronic diseases and their treatment. Remarkably, sleep genetics has been emerging as one of the important features in sleep research [8, 9]. Several studies have demonstrated that genetic background or certain gene products can affect individual sleep patterns [10]. Investigation of these candidate genes can help identify the molecular machinery responsible for both normal sleep and sleep-related disorders.

Reverse transcription (RT) followed by quantitative real time PCR (qPCR) is one of the most compelling approaches for gene expression analysis due to speed and simplicity of the method [11]. Potential methodological variations can be corrected by normalizing the gene expression of interest to a set of references, frequently referred to as housekeeping genes, which presumably maintain constitutive expression. However, increasing evidence has demonstrated that the expression of commonly used reference genes, such as b-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), can vary under certain circumstances [12, 13]. Consequently, the selection and validation of reference genes for the tissue and experimental conditions of interest is a critical step to generate reliable results using RTqPCR methodology.

Herein, the expression stability (M) of four common reference genes (Table 1) was evaluated in brain and blood collected from control and sleep deprived rats, using GeNorm software [14]. In order to validate the selected reference genes, the expression of brain derived neurotrophic factor (BDNF) and glycerol-3-phosphate dehydrogenase1 (GPD1) was examined in brain and blood, respectively, as the expression of these genes has been shown to vary with sleep deprivation [15, 16].
Table 1

Candidate genes with respective gene accession number and primer sequences

Gene name

Access number

Primer sequences (5'-3')

beta-actin

NM_031144

AGCGTGGCTACAGCTTCACC

  

AAGTCTAGGGCAACATAGCACAGC

beta-2-microglobulin (B2M)

Y00441

GCCATCCACCGGAGAATG

  

GGTGGAACTGAGACACGTAGCA

glyceraldehyde-3-phosphate

NM_017008

TGCCCCCATGTTTGTGATG

dehydrogenase (GAPDH)

 

GCTGACAATCTTGAGGGAGTTGT

hypoxanthine guanine

NM_012583

GCGAAAGTGGAAAAGCCAAGT

phosphoribosyl transferase (HPRT)

 

GCCACATCAACAGGACTCTTGTAG

brain derived neurotrophic

NM_012513

ATGCCGAACTACCCAATCGT

factor (BDNF)

 

GCCAATTCTCTTTTTGCTATCCA

glycerol-3-phosphate

NM_022215

TGGCCCCTTTCCAAGGTT

dehydrogenase 1 (GPD1)

 

TCCAGGCTGCTGATCTGTGA

Results

RNA quality

RNA quality is one of the most important factors that determine the precision of RTqPCR. In order to evaluate the quality of the DNase I treated RNA, we performed electrophoresis in agarose gel. All RNA samples used in this study exhibited intact 28 S and 18 S rRNA and similar banding patterns (Figure 1), indicating that degradation of RNA was negligible. Also, the absence of high molecular weight molecules suggested that contamination with genomic DNA was minimal. These data demonstrated that the RNA samples used for this study were of appropriate quality to perform RTqPCR.
Figure 1

Representative image of electrophoresis of total RNA in agarose gel. Total RNA extracted from brain of controls (1, 2, 3) and rats subjected to paradoxical sleep deprivation without (4, 5, 6) or with sleep recovery (7, 8, 9) was fractioned in agarose gel 1%. Approximately 1.5 μg of RNA was loaded for each sample. Intact 28 S and 18 S rRNA were observed without higher molecular weight molecules.

RTqPCR

Pilot experiments were performed with b-actin primers to determine the optimal amounts of RNA and cDNA that result in Ct values within the linear range. A total of 0.3 μg of RNA, treated with DNase I, was used for the 20 μL reverse transcription reaction and 2 μL of cDNA was used for qPCR. Subsequently, the same amounts of RNA and cDNA were used for all reactions producing Ct values within 15.0 to 33.0 ranges. Analysis of each amplification product produced a dissociation curve containing a single peak with narrow melting temperature (Table 2), indicating that each primer pair amplified a single predominant product.
Table 2

Melting temperature (°C) of amplification products with standard deviations.

Tissue

Beta-actin

B2M

GAPDH

HPRT

GOI

Brain

81.0 ± 0.2

79.5 ± 0.2

77.7 ± 0.3

78.2 ± 0.2

77.9 ± 0.1

Blood

81.1 ± 0.2

79.6 ± 0.2

77.7 ± 0.3

78.3 ± 0.2

80.1 ± 0.3

GOI: gene of interest (BDNF for brain and GPD1 for blood).

Expression stability of the reference genes

The expression of b-actin, B2M, GAPDH and HPRT was measured in two independent experiments where the rats were distributed into three groups: controls (C), animals subjected to paradoxical sleep deprivation for 96 hours (PSD96) and animals subjected to PSD96 and then a sleep recovery period of 24 hours (SR24). In the second experiment, a group of animals subjected to total sleep deprivation for 6 hours (TSD6) was included. For all samples, qPCR was performed at least in duplicate and reproducible Ct values were obtained with correlation coefficient > 0.99 (p < 0.0001) for both experiments.

The data from C, PSD96 and SR24 groups were arrayed in a single matrix for the calculation of M values. To assess the variability between the experiments, M values were calculated for each experiment separately. The data of TSD6 and respective control groups were analyzed in a distinct matrix in order to discriminate the effect of PSD from the TSD. As shown in Table 3, all genes presented relatively low M values for both protocols of sleep deprivation. Although the best pair of reference genes (lowest M values) varied between the two experiments, the four genes can be considered suitable reference genes for sleep-related gene expression studies, according to the previously suggested cut-off of M value (0.5) for a stable reference gene [17].
Table 3

Reference genes with their respective M-values in three distinct experiments.

 

Brain

Blood

 

Exp_1

Exp_2

Exp_3

Exp_1

Exp_2

Exp_3

Actin

0.163

0.160

0.152

0.234

0.159

0.217

B2M

0.110

0.160

0.166

0.309

0.226

0.162

GAPDH

0.092

0.195

0.197

0.157

0.159

0.162

HPRT

0.092

0.176

0.152

0.157

0.370

0.377

Exp_1 and Exp_2 contained 3 groups: Control, PSD96 and SR24. Exp_3 contained 2 groups: control and TSD6.

To distinguish the effect of sleep deprivation on gene expression stability, M values were also calculated for each group (C, PSD96, SR24 and TSD6) independently, but all M values were below the cut-off (0.5), suggesting that total or paradoxical sleep deprivation did not alter the expression stability of commonly used reference genes.

Validation of the reference genes

To validate the selected reference genes, the expression of BDNF was determined by RTqPCR in brain. Relative expression fold changes were calculated by the 2-ΔΔCT method [18] using b-actin, B2M, GAPDH or HPRT as the reference genes as well as by using the normalization factor (NF) derived from the geometric mean of four reference genes [14].

The normalization with each reference gene or with the NF produced consistent results showing that PSD96 did not alter the BDNF expression compared to the control (Figure 2A, p > 0.05). However, conflicting results were obtained regarding the effect of sleep recovery. While b-actin or HPRT generated slight, but statistically significant decrease in BDNF expression for the SR24 group (p < 0.05 and p < 0.001 for b-actin and HPRT respectively), the use of B2M, GAPDH or NF as references did not produced a similar reduction compared to the control (p > 0.05, Figure 2A).
Figure 2

Expression of BDNF in the brain. A. The expression of BDNF was quantified by RTqPCR in the brain of controls (C), animals subjected to paradoxical sleep deprivation for 96 hours (PSD96), and animals subjected to PSD and sleep recovery for 24 hours (SR24). B. The expression of BDNF was also evaluated in animals subjected to total sleep deprivation for 6 hours (TSD6) and compared to the control (C). The relative expression fold changes were calculated using the 2-ddCt method for each reference gene or the normalization factor (NF) generated by GeNorm software. Error bar represents standard error of the mean. * p < 0.05 compared to control, # p < 0.05 compared to PSD (ANOVA followed by Tukey's post hoc test).

In a similar way, the effect of TSD6 was also statistically variable depending on the selection of the reference gene: normalization with B2M, GAPDH or NF resulted in significant increase of BDNF expression compared to the control (p < 0.05), while the use of b-actin or HPRT did not validate the effect of TSD (p > 0.05, Figure 2B).

In blood, the expression of GPD1 was evaluated since sleep and metabolism are closely related and that GPD1 is one of the key intermediates between the carbohydrate and lipid metabolism [19]. All reference genes and NF resulted in a significant increase of GPD1 expression in PSD96 group compared to the controls (p < 0.05) but the magnitude of fold changes was somewhat different between each analysis (Figure 3A). In SR24 group, the mean relative expression was increased by at least two fold compared to the controls, but it did not reach statistical significance, probably due to high individual variability (p > 0.05).
Figure 3

Expression of GPD1 in the blood. A. The expression of GPD1 was measured by RTqPCR in the blood of controls (C), animals subjected to paradoxical sleep deprivation for 96 hours (PSD96) and animals subjected to PSD and sleep recovery for 24 hours (SR24). B. The expression of GPD1 was also evaluated in animals subjected to total sleep deprivation for 6 hours (TSD6) and compared to the control (C). The relative expression fold changes were calculated using the 2-ddCt method for each reference genes or the normalization factor (NF) generated by GeNorm software. Error bar represents standard error of the mean. * p < 0.05 compared to control (ANOVA followed by Tukey's post hoc test).

TSD6 was not sufficient to produce similar increase in GPD1 expression, and all reference genes and NF generated consistent results (p > 0.05, Figure 3B).

Discussion

Effects of sleep deprivation on the expression of classical reference genes

Given the importance of the genetic aspect of sleep research, substantial efforts were made to identify genes involved in sleep-wake cycles. These studies reported that sleep deprivation can modify the expression of genes frequently used as internal controls for RTqPCR [20]. For instance, short-term sleep deprivation altered the expression of cytoskeletal proteins such as beta-actin and tubulin in two independent proteomic analyses [12, 21]. Furthermore, Biswas and colleagues showed that the amount of actin and tubulin decreased in the brains of paradoxical sleep-deprived rats and culminated in neuronal apoptosis [22]. GAPDH is another classical reference gene that requires careful analysis before using in sleep-related gene expression studies. Several studies demonstrated that sleep deprivation or sleep disorders alter glucose metabolism and enhance the risk for type 2 diabetes [7]. Thus, despite lack of direct evidence, the strong correlation between sleep and glucose metabolism suggests that the expression and/or activity of GAPDH might be modulated by the sleep-wake cycle.

These findings strongly justified the importance of the present study and our data demonstrated that the most commonly used reference genes presented stable expression throughout the total or paradoxical sleep deprivation period, as the M values were below the cut-off previously suggested for stable genes [17].

Expression of BDNF in the brain

Brain-derived neurotrophic factor (BDNF) is an important mediator of memory and cognition and its expression is strongly modulated by neuronal activity [15]. In our previous study, we observed that the PSD96 increased the expression of BDNF in cortical tissue [16] while other group showed that BDNF expression was reduced by 6 h of PSD in the cerebellum and brainstem [23]. In the present study, we did not observe any alteration of BDNF expression in paradoxical sleep deprived rats. Conceivably, distinct regulation of BDNF expression may occur throughout the different regions of the brain and therefore, the use of whole brain might mask the effect of PSD on specific region of the brain. On the other hand, the intracerebral injection of exogenous BDNF in rat increased the time spent in NREM sleep without affecting REM sleep [24]. These data spare the possibility of BDNF expression being minimally affected by PSD in many areas of the brain corroborating the present findings.

In contrast, the short-term total sleep deprivation appears to up-regulate the expression of BDNF in various regions of the brain [15, 2527] suggesting that the use of whole brain would not interfere with the gene expression results. As expected, an overall increase in mean relative expression of BDNF was observed in TSD6 group, but the statistical significance was achieved only when B2M, GAPDH or NF were used for the normalization, although all tested reference genes presented stable expression stability. These data illustrated that use of single reference gene can produce flawed results leading to misinterpretation of physiological events. Thus, the application of multiple reference genes in RTqPCR is desirable for reliable results.

Expression of GPD1 in blood

The reduction of sleep time and augment of obese individuals in modern life are concurrent trends indicating that sleep-wake cycle has strong impacts on the energy metabolism [28]. GPD1 is a NAD+ dependent cytosolic enzyme that generates key intermediates between glucose and lipid metabolism [19]. In our previous studies, we found that GPD1 expression was increased in cortex and blood of rat subjected to PSD96 compared to controls [16]. Although the increase of GPD1 expression followed by PSD96 was confirmed in this study, short-term TSD did not have significant effect on the expression of this gene. Several studies have demonstrated that the alteration of biochemical parameters can occur even after short period of sleep deprivation [2931]. Thus, the increase of GPD1 expression occurred after PSD96 can be a secondary effect of prolonged paradoxical sleep loss. Finally, the fact that both BDNF and GPD1 expression was differently modulated by PSD and TSD demonstrates the importance of distinct protocols of sleep deprivation in order to discriminate events that happen in each stage of sleep at distinct time course.

Conclusion

This study demonstrated that the most commonly used reference genes are suitable for gene expression studies that involve sleep deprivation. However, more reliable results of RTqPCR can be obtained when multiple reference genes are used.

Methods

Selection of reference genes

In order to avoid possible co-regulation of expression, genes belonging to distinct biological pathways were selected as follows: beta-actin (b-actin), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta-2-microglobulin (B2M) and hypoxanthine guanine phosphoribosyl transferase (HPRT). Brain derived neurotrophic factor (BDNF) and glycerol-3-phosphate dehydrogenase 1 (GPD1) were used to validate the reference genes. Gene accession numbers as well as primer sequences are listed in Table 1.

Sleep deprivation

Adult male Wistar-Hannover rats were assigned to three groups (3 animals/group): home-cage controls (C), rats subjected to PSD for 96 hours (PSD96) [32], and rats subjected to PSD96 with an additional sleep recovery period of 24 hours (SR24). In the second experiment, 9 animals per group were used and an additional group of 8 animals was included for a total sleep deprivation of 6 hours (TSD6). During the PSD, the rats were placed on narrow circular platforms located inside a tank (143 cm × 41 cm × 30 cm), which is filled with water of ~1 cm depth. When rats reach the paradoxical phase of sleep, they fall into the water, due to muscle atonia, and wake up. This protocol causes deprivation of all sleep stages on the first day, and then becomes more selective leading to the complete loss of paradoxical sleep on subsequent days. TSD was achieved by gentle handling method as described elsewhere [33]. The rats used in this study were maintained and treated according to the ethical and practical guidelines for the use of laboratory animal. The experimental protocol has the approval of the Ethical Committee of UNIFESP (CEP N. 05/434). Maximum efforts were taken to use the smallest, but enough number of animals in the experiments to ensure unambiguous and reliable statistical analysis and data interpretation.

Tissue collection and total RNA extraction

The animals were decapitated immediately after sleep deprivation and sleep recovery procedure. The brain was rapidly dissected, flash frozen in liquid nitrogen, and then stored at -80°C until RNA extraction. Total RNA was extracted from whole tissues using Trizol reagent (Invitrogen) according to the manufacturer's instructions. After decapitation, neck blood samples (2.5 mL) were collected in PaxGene RNA collection tubes (PreAnalytiX) according to the manufacturer's recommendations. Two hours after collection, total RNA was extracted using PaxGene blood RNA isolation kit (PreAnalytiX) with minor modification [34]. After RNA extraction, RNA was treated with DNaseI and the quality of the RNA was evaluated by electrophoresis in agarose gel.

Reverse transcription and quantitative Real time PCR (RTqPCR)

Total RNA was reverse transcribed into cDNA using SuperScript™ III Platinum® Two-Step qRT-PCR kit with SYBER® Green (Invitrogen). Reverse transcription was performed at 25°C for 10 min, 42°C for 50 min and then 85°C for 10 min. Each cDNA sample was then used as a template for real-time PCR amplification using the same kit (Invitrogen). Amplification and detection was performed using an Applied Biosystems 7500 Real-Time PCR system (Applied Biosystems) according to the manufacturer's instructions using a two-stage cycle (95°C for 15 s and 60°C for 1 min) repeated 40 times followed by a dissociation stage.

Data analysis

Gene stability was evaluated using GeNorm algorithm, freely available for download http://medgen.ugent.be/~jvdesomp/genorm/. The GeNorm algorithm relies on the principle that the expression ratio of two ideal reference genes must be constant between samples [14]. This software calculates the variation of this ratio for all two-by-two combinations of reference genes. Lower M values indicate higher expression stability, with 0.5 being a suggested cut-off for stable genes [17]. The expression fold changes of BDNF and GPD1 were calculated by the 2-ΔΔCT method for each reference genes [18], or by the 2-ΔCT method using the geometric mean of suitable reference genes as the normalization factor [14]. Unpaired t-test or Analysis of variance (ANOVA) followed by Tukey post hoc test was conducted on the relative expression values using software GraphPad Prism (v 4.00).

List of abbreviations

(b-actin)

Beta-actin

(B2M)

beta-2-microglobulin

(BDNF)

brain derived neurotrophic factor

(C): 

Control group

(Ct): 

threshold cycle

(GPD1): 

glycerol-3-phosphate dehydrogenase 1

(PSD96): 

paradoxical sleep deprivation for 96 hours

(RTqPCR): 

reverse transcription quantitative polymerase chain reaction

(SR24): 

sleep recovery for 24 hours

(TSD6): 

total sleep deprivation for 6 hours.

Declarations

Acknowledgements

This study was supported by Associação Fundo de Incentivo à Psicofarmacologia (AFIP), CNPq and Fundação de Amparo à Pesquisa do Estado de São Paulo (CEPID #98/14303-3 to ST and 06/58274-5 to TAA). KSL is a recipient of a fellowship of AFIP. MLA and ST are recipients of fellowships from CNPq.

Authors’ Affiliations

(1)
Associação Fundo de Incentivo à Psicofarmacologia (AFIP)
(2)
Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP)

References

  1. Stickgold R: Sleep: the ebb and flow of memory consolidation. Curr Biol. 2008, 18 (10): R423-425.View ArticlePubMedGoogle Scholar
  2. Mignot E: Why we sleep: the temporal organization of recovery. PLoS Biol. 2008, 6 (4): e106-PubMed CentralView ArticlePubMedGoogle Scholar
  3. Banks S, Dinges DF: Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med. 2007, 3 (5): 519-528.PubMed CentralPubMedGoogle Scholar
  4. Van Dongen HP, Maislin G, Mullington JM, Dinges DF: The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003, 26 (2): 117-126.PubMedGoogle Scholar
  5. Alvarez GG, Ayas NT: The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs. 2004, 19 (2): 56-59.View ArticlePubMedGoogle Scholar
  6. Goncalves MA, Guilleminault C, Ramos E, Palha A, Paiva T: Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med. 2005, 6 (4): 333-339.View ArticlePubMedGoogle Scholar
  7. Tasali E, Mokhlesi B, Van Cauter E: Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008, 133 (2): 496-506.View ArticlePubMedGoogle Scholar
  8. Tafti M: Quantitative genetics of sleep in inbred mice. Dialogues Clin Neurosci. 2007, 9 (3): 273-278.PubMed CentralPubMedGoogle Scholar
  9. Lamont EW, James FO, Boivin DB, Cermakian N: From circadian clock gene expression to pathologies. Sleep Med. 2007, 8 (6): 547-556.View ArticlePubMedGoogle Scholar
  10. Maret S, Dorsaz S, Gurcel L, Pradervand S, Petit B, Pfister C, Hagenbuchle O, O'Hara BF, Franken P, Tafti M: Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci USA. 2007, 104 (50): 20090-20095.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Peirson SN, Butler JN: Quantitative polymerase chain reaction. Methods Mol Biol. 2007, 362: 349-362.View ArticlePubMedGoogle Scholar
  12. Poirrier JE, Guillonneau F, Renaut J, Sergeant K, Luxen A, Maquet P, Leprince P: Proteomic changes in rat hippocampus and adrenals following short-term sleep deprivation. Proteome Sci. 2008, 6 (1): 14-PubMed CentralView ArticlePubMedGoogle Scholar
  13. Coulson DT, Brockbank S, Quinn JG, Murphy S, Ravid R, Irvine GB, Johnston JA: Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol. 2008, 9: 46-PubMed CentralView ArticlePubMedGoogle Scholar
  14. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3 (7): RESEARCH0034-PubMed CentralView ArticlePubMedGoogle Scholar
  15. Cirelli C, Tononi G: Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J Neurosci. 2000, 20 (24): 9187-9194.PubMedGoogle Scholar
  16. Guindalini CAM, Alvarenga T, Lee K, Tufik S: To what extent is sleep rebound effective in reversing the effects of paradoxical sleep deprivation on gene expression in the brain?. Behavioural Brain Research. 2009, 201 (1): 53-58.View ArticlePubMedGoogle Scholar
  17. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J: qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8 (2): R19-PubMed CentralView ArticlePubMedGoogle Scholar
  18. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408.View ArticlePubMedGoogle Scholar
  19. Turyn J, Schlichtholz B, Dettlaff-Pokora A, Presler M, Goyke E, Matuszewski M, Kmiec Z, Krajka K, Swierczynski J: Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm Metab Res. 2003, 35 (10): 565-569.View ArticlePubMedGoogle Scholar
  20. Jones S, Pfister-Genskow M, Benca RM, Cirelli C: Molecular correlates of sleep and wakefulness in the brain of the white-crowned sparrow. J Neurochem. 2008, 105 (1): 46-62.View ArticlePubMedGoogle Scholar
  21. Pawlyk AC, Ferber M, Shah A, Pack AI, Naidoo N: Proteomic analysis of the effects and interactions of sleep deprivation and aging in mouse cerebral cortex. J Neurochem. 2007, 103 (6): 2301-2313.View ArticlePubMedGoogle Scholar
  22. Biswas S, Mishra P, Mallick BN: Increased apoptosis in rat brain after rapid eye movement sleep loss. Neuroscience. 2006, 142 (2): 315-331.View ArticlePubMedGoogle Scholar
  23. Sei H, Saitoh D, Yamamoto K, Morita K, Morita Y: Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res. 2000, 877 (2): 387-390.View ArticlePubMedGoogle Scholar
  24. Kushikata T, Fang J, Krueger JM: Brain-derived neurotrophic factor enhances spontaneous sleep in rats and rabbits. Am J Physiol. 1999, 276 (5 Pt 2): R1334-1338.PubMedGoogle Scholar
  25. Cirelli C, Tononi G: Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000, 885 (2): 303-321.View ArticlePubMedGoogle Scholar
  26. Taishi P, Sanchez C, Wang Y, Fang J, Harding JW, Krueger JM: Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity. Am J Physiol Regul Integr Comp Physiol. 2001, 281 (3): R839-845.PubMedGoogle Scholar
  27. Fujihara H, Sei H, Morita Y, Ueta Y, Morita K: Short-term sleep disturbance enhances brain-derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor. J Mol Neurosci. 2003, 21 (3): 223-232.View ArticlePubMedGoogle Scholar
  28. Laposky AD, Bass J, Kohsaka A, Turek FW: Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett. 2008, 582 (1): 142-151.View ArticlePubMedGoogle Scholar
  29. Spiegel K, Tasali E, Penev P, Van Cauter E: Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004, 141 (11): 846-850.View ArticlePubMedGoogle Scholar
  30. Bodosi B, Gardi J, Hajdu I, Szentirmai E, Obal F, Krueger JM: Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol. 2004, 287 (5): R1071-1079.View ArticlePubMedGoogle Scholar
  31. Andersen ML, Martins PJ, D'Almeida V, Bignotto M, Tufik S: Endocrinological and catecholaminergic alterations during sleep deprivation and recovery in male rats. J Sleep Res. 2005, 14 (1): 83-90.View ArticlePubMedGoogle Scholar
  32. Tufik S, Lindsey CJ, Carlini EA: Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?. Pharmacology. 1978, 16 (2): 98-105.View ArticlePubMedGoogle Scholar
  33. Morrow JD, Opp MR: Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun. 2005, 19 (1): 28-39.View ArticlePubMedGoogle Scholar
  34. Fannin RD, Auman JT, Bruno ME, Sieber SO, Ward SM, Tucker CJ, Merrick BA, Paules RS: Differential gene expression profiling in whole blood during acute systemic inflammation in lipopolysaccharide-treated rats. Physiol Genomics. 2005, 21 (1): 92-104.View ArticlePubMedGoogle Scholar

Copyright

© Lee et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement